Effectiveness of secukinumab for the treatment of erythrodermic psoriasis: Multicentre study in daily practice-Reference-Cited by-同舟云学术

Effectiveness of secukinumab for the treatment of erythrodermic psoriasis: Multicentre study in daily practice

Published:2023-08-07 Issue: Volume: Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Reymundo A.¹^ORCID,Armesto S.²,Rodríguez L.³,Baniandrés O.⁴,Sahuquillo‐Torralba A.⁵,Torres T.⁶^ORCID,de la Cueva P.⁷,Llamas‐Velasco M.¹^ORCID,Daudén E.¹^ORCID

Affiliation:

1. Dermatology Department Hospital universitario de la Princesa, Instituto de Investigación Sanitaria de La Princesa (IIS‐IP) Madrid Spain

2. Dermatology Department Hospital Universitario Marqués de Valdecilla Santander Spain

3. Dermatology Department Hospital Universitario Virgen del Rocío Sevilla Spain

4. Dermatology Department Hospital General Universitario Gregorio Marañón Madrid Spain

5. Dermatology Department Hospital Universitario y Politécnico la Fe Valencia Spain

6. Dermatology Department Centro Hospitalar e Universitario do Porto Porto Portugal

7. Dermatology Department Hospital Universitario Infanta Leonor Madrid Spain

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.19371

Reference6 articles.

1. Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

2. Successful Secukinumab treatment of generalized pustular psoriasis and erythrodermic psoriasis

3. Erythrodermic psoriasis and secukinumab: Our clinical experience

4. Two cases of refractory erythrodermic psoriasis effectively treated with secukinumab and a review of the literature

5. Use of Secukinumab in a Cohort of Erythrodermic Psoriatic Patients: A Pilot Study